T
he diagnosis of abdominal wall endometriosis (AWE) is made when endometrial tissue superficial to the peritoneum is confirmed by histopathology. The incidence of cesarean scar endometriosis is estimated between 0.03% and 0.45%, and patients most commonly present with a mass (96%) and pain (87%; 57% of whom experience cyclical discomfort associated with menstruation). [1] [2] [3] The infiltrative nature of endometrial tissue can result in large or recurrent lesions which require wide excision and removal of the bilateral ovaries to achieve an optimal therapeutic outcome. Due to association with the abdomen and prior incision, the differential diagnosis includes incisional hernia, keloid scarring, desmoid tumor, suture granuloma, fat necrosis, or malignancy.
The treatment of choice for AWE is wide local excision with at least 1 cm margins, and recurrence is estimated at 4.3%. 4 Although AWE is well documented in the literature as a late complication following cesarean section, the average reported size (2.7 cm) typically lends toward primary fascial closure following resection. 3 In cases of large abdominal wall defects, options for closure include unilateral or bilateral component separation, bridging interposition mesh, or musculofasciocutaneous/fasciocutaneous free flap.
CASE REPORT
A 31-year-old African American woman with a history of 2 low transverse cesarean sections and prior resection of abdominal scar endometrioma 5 years ago presented with a recurrent Pfannenstiel incision-associated mass and chronic, severe pain uncontrolled by maximal medical therapy. Computed tomography with contrast of the abdomen and pelvis demonstrated evidence of an infiltrative soft tissue mass involving the right lower quadrant ventral abdominal wall musculature and subcutaneous tissues measuring 8.8 cm × 4.0 cm (Fig. 1) . The patient was evaluated by a multidisciplinary team including surgical oncology sarcoma specialists, obstetrics and gynecology, and plastic and reconstructive surgery for surgical planning of wide excision and repair.
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The patient had an uncomplicated postoperative hospital stay and was discharged on postoperative day 5. Follow-up out to 6 months did not demonstrate clinical nor radiographic evidence of hernia recurrence or bulge.
DISCUSSION
This case presents an interesting challenge in surgical planning and reconstruction due to a multitude of factors: the unknown extent of resection necessary before time of repair, wide inferior defect with pubic bone exposure, inherent contamination associated with concomitant gynecologic procedure, and need for mass pathology and sufficient margin confirmation. This defect, which spans several quadrants of the MD Anderson oncologic abdominal wall reconstruction classifications (type V), typically relies on a bridging mesh repair. 5 Additionally, due to the inherent field contamination, a biologic ADM was selected to mitigate infection risk. 6 Finally, the need to confirm mass pathology and sufficient margins on permanent section indicated a possibility of reresection which would risk damage to any permanent mesh and primary fascial closure. The combination of these factors led to the decision to forgo component separation to preserve the patient's musculofascial integrity for a final repair during which field contamination and pathology could be controlled.
This repair balanced patient-specific factors with plastic surgical principles to minimize morbidity. However, patients receiving abdominal wall reconstruction with use of ADM in the setting of oncologic extirpation have a high likelihood of hernia recurrence (odds ratio = 6.47). 7 Additionally, bridging mesh predisposes patients to risk of hernia recurrence (56% with biologic mesh used as an interposition bridge) and infection (25%). 8, 9 Therefore, a multidisciplinary approach, adequate patient counseling of expectations, and intraoperative flexibility are needed to address unique complications or scenarios following wide, deep excisions that significantly alter the structural integrity of the abdomen. 10 Plastic and reconstructive surgeons well versed in complex abdominal wall repairs play an integral role in the treatment of these patients as they can best address current defects and hedge against future complications.
CONCLUSIONS
Resection and repair of infiltrative AWE require a multidisciplinary approach and intraoperative problem solving by plastic surgeons familiar with complex abdominal wall repairs. Additionally, likelihood of recurrence requires surgical foresight in case of future necessary repairs following additional resections.
